Comparative Effectiveness of Antihypertensive Therapeutic Classes and Treatment Strategies in the Initiation of Therapy in Primary Care Patients: A Distributed Ambulatory Research in Therapeutics Network (DARTNet) Study

References

1. 1.↵
   1. Roger VL,
   2. Go AS,
   3. Lloyd-Jones DM,
   4. et al

   . Executive summary: heart disease and stroke statistics–2012 update: a report from the American Heart Association. Circulation 2012; 125:188–97.

   OpenUrlFREE Full Text
2. 2.↵
   1. Lewington S,
   2. Clarke R,
   3. Qizibash N,
   4. Peto R,
   5. Collins R

   . Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies: prospective studies collaboration. Lancet 2002; 360:1903–13.

   OpenUrlCrossRefPubMedWeb of Science
3. 3.↵
   1. Collins R,
   2. Peto R,
   3. MacMahon S,
   4. et al

   . Blood pressure, stroke, and coronary heart disease. Part 2: short-term reductions in blood pressure: overview of randomized drug trials in their epidemiological context. Lancet 1990; 335:827–38.

   OpenUrlCrossRefPubMedWeb of Science
4. 4.↵
   1. Turnbull F

   . Blood Pressure Lowering Treatment Trialists' Collaboration: effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomized trials. Lancet 2003; 362:1527–35.

   OpenUrlCrossRefPubMedWeb of Science
5. 5.↵
   1. Chobanian AV,
   2. Bakris GL,
   3. Black HR,
   4. et al

   ; The National High Blood Pressure Education Program Coordinating Committee. Seventh report of the Joint National Committee On Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206–52.

   OpenUrlCrossRefPubMed
6. 6.↵
   1. Cushman WC,
   2. Ford CE,
   3. Cutler JA,
   4. et al

   ; ALLHAT Collaborative Research Group. Success and predictors of blood pressure control in diverse North American settings: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2002; 4:393–404.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Bakris GL,
   2. Weir MR

   .; Study of Hypertension and the Efficacy of Lotrel in Diabetes (SHIELD) Investigators. Achieving goal blood pressure in patients with type 2 diabetes: Conventional versus fixed-dose combination approaches. J Clin Hypertens (Greenwich) 2003; 5:202–9.

   OpenUrlPubMed
8. 8.↵
   1. Brown MJ,
   2. McInnes GT,
   3. Papst CC,
   4. Zhang J,
   5. MacDonald TM

   . Aliskiren and the calcium channel blocker Amlodipine combination as an initial treatment strategy for hypertension control (ACCELERATE): a randomised, parallel-group trial. Lancet 2011; 377:312–20.

   OpenUrlCrossRefPubMedWeb of Science
9. 9.↵
   1. Neutel JM,
   2. Mancia G,
   3. Black HR,
   4. et al

   ; TEAMSTA Severe HTN Study Investigators. Single-pill combination of telmisartan/amlodipine in patients with severe hypertension: results from the TEAMSTA Severe HTN Study. J Clin Hypertens (Greenwich) 2012; 14:206–15.

   OpenUrlPubMed
10. 10.↵
    1. Baser O,
    2. Andrews LM,
    3. Wang L,
    4. Xie L

    . Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine singe-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy. J Med Econ 2011; 14:576–83.

    OpenUrlPubMed
11. 11.↵
    1. Sherrill B,
    2. Halpern M,
    3. Khan S,
    4. Zhang J,
    5. Panjabi S

    . Single-pill vs. free-equivalent combination therapies for hypertension: a meta-analysis of health care costs and adherence. J Clin Hypertens 2011; 13:898–909.

    OpenUrl
12. 12.↵
    1. Libby AM,
    2. Pace W,
    3. Bryan C,
    4. et al

    . Comparative effectiveness research in DARTNet primary care practices: point of care data collection on hypoglycemia and over-the-counter and herbal use among patients diagnosed with diabetes. Med Care 2010; 48:S39–44.

    OpenUrlPubMed
13. 13.↵
    1. Pace WD,
    2. Cifuentes M,
    3. Valuck RJ,
    4. Staton EW,
    5. Brandt EC,
    6. West DR

    . An electronic practice-based network for observational comparative effectiveness research. Ann Intern Med 2009; 151:338–40.

    OpenUrlCrossRefPubMedWeb of Science
14. 14.↵
    1. Pace WD,
    2. West DR,
    3. Valuck RJ,
    4. Cifuentes M,
    5. Staton EW

    . Distributed Ambulatory Research in Therapeutics Network (DARTNet): summary report (prepared by University of Colorado DEcIDE Center under contract no. HHSA29020050037I TO2). Report No. 14. Rockville, MD: Agency for Healthcare Research and Quality; 2009.
15. 15.↵
    1. Levely AS,
    2. Stevens LA,
    3. Schmid CH,
    4. et al

    . A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604–12.

    OpenUrlCrossRefPubMedWeb of Science
16. 16.↵
    1. Law MR,
    2. Wald NJ,
    3. Morris JK,
    4. Jordan RE

    . Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ 2003; 326:1427.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Neaton JD,
    2. Grimm RH Jr.,
    3. Prineas RJ,
    4. et al

    . Treatment of Mild Hypertension Study. JAMA 1993; 270:713–24.

    OpenUrlCrossRefPubMedWeb of Science
18. 18.↵
    1. Cushman WC,
    2. Ford CE,
    3. Einhorn PT,
    4. et al

    ; ALLHAT Collaborative Research Group. Blood pressure control by drug group in the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). J Clin Hypertens (Greenwich) 2008; 10:751–60.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Materson BJ,
    2. Reda DJ,
    3. Cushman WC,
    4. et al

    . Single-drug therapy for hypertension in men. N engl J Med 1993; 328:914–21.

    OpenUrlCrossRefPubMedWeb of Science
20. 20.↵
    1. Byrd JB,
    2. Zeng C,
    3. Tavel HM,
    4. et al

    . Combination therapy as initial treatment for newly diagnosed hypertension. Am Heart J 2011; 162:340–6.

    OpenUrlCrossRefPubMedWeb of Science
21. 21.↵
    1. Egan BM,
    2. Bandyopadhyay D,
    3. Shaftman SR,
    4. Wagner CS,
    5. Zhao Y,
    6. Yu-Isenber KS

    . Initial monotherapy and combination therapy and hypertension control the first year. Hypertension 2012; 59:1124–31.

    OpenUrlCrossRef
22. 22.↵
    1. Gradman AH,
    2. Basile JN,
    3. Carter BL,
    4. Bakris GL

    . Combination therapy in hypertension. J Am Soc Hypertens 2010; 4:42–50.

    OpenUrlCrossRefPubMed
23. 23.↵
    1. Wald DS,
    2. Law M,
    3. Morris JK,
    4. Bestwick JP,
    5. Wald NJ

    . Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med 2009; 122:243–62.

    OpenUrl